Patent · US Active

Morphinan derivative

US8952030B2 · kind B2 · utility

6Cited by
0References
30Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 7, 2012
Grant dateFeb 10, 2015
Priority date—
Expiry dateSep 7, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F7/1804
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A morphinan derivative represented by the following general formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.